EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants

Michela Palleschi, Alessandra Virga iD, Emanuela Scarpi, Eugenio Fonzi, Antonino Musolino, Filippo Merloni, Samanta Sarti, Rita Danesi, Mila Ravegnani, Chiara Casadei, Marianna Sirico, Caterina Gianni und 13 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyaf052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Michela Palleschi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Breast & GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, 47014, Italy. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Genetic Predisposition to Disease, Germ-Line Mutation, Promoter Regions, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current genetic screening for predisposition to breast cancer (BC) is limited to BRCA1/2 exons and intron/exon boundaries, and limited information exists about the impact of variants in BRCA1/2 non-coding regions. The majority of alterations identified in these regions remain unclassified, but evidence of the impact of variants in the regulatory regions on cancer risk and response to treatment is emerging. Patients and methods This project aimed to investigate the prevalence of germline variants in the non-coding regulatory regions of BRCA1/2 and other BC predisposition genes in patients with triple-negative BC (TNBC) selected for age at cancer diagnosis and/or family history of cancer. The study also aims to investigate the relationship between these variants and clinical outcomes such as overall survival, disease-free survival (DFS), and response to treatment. We analyzed a Next-Generation Sequencing (NGS) custom panel of promoter regions of 28 genes involved in BC predisposition on 144 patients with TNBC previously tested wild type for coding regions of BRCA1/2.

Results

The NGS analysis identified 635 rare variants in promoter regions of the 28 genes. Among the 144 patients, for 75 with available clinical data, rare germline variants in BRCA2 promoter were statistically significantly related to worse overall survival (OS) (P-value = .017). No differences in DFS and OS were found for the other genes. Rare variants in the CDH1 promoter were related to the highest percentage of non-pathological complete response after neoadjuvant chemotherapy (P = .0273); MLH1 and PALB2 rare non-coding variants were found to be both related to bilateral BC (P = .0146 and P = .0005, respectively) and ATM promoter variants were associated with a positive family history (P = .041).

Conclusion

Our results underscore the importance of searching for rare germline variants in regulatory regions of cancer predisposition genes in patients with TNBC, since these variants can be associated with an increased cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsGenetic Predisposition to DiseaseGerm-Line MutationPromoter Regions, GeneticHumansFemaleMiddle AgedAdultAgedBRCA2 ProteinBRCA1 ProteinHigh-Throughput Nucleotide SequencingFanconi Anemia Complementation Group N Protein

Stichwörter der Autor:innen

cancer predispositionhereditary breast cancerpromoter variantsregulatory regionstriple-negative breast cancer

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA2 protein, humanBRCA1 protein, humanFanconi Anemia Complementation Group N Protein

Autor:innen und Institutionen

  • Medical Oncology, Breast & GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, 47014, Italy.
  • Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, 47014, Italy.
  • Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014, Meldola, Italy.
  • Department of Medical and Surgical Science, University of Bologna, Bologna, 40138, Italy.
  • Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, 47014, Italy.
  • Local Health Authority, Cancer Prevention Unit, Forlì, 47121, Italy.

ORCID-Profile: Alessandra Virga, Sara Bravaccini

Zitieren

APA

Palleschi, M., Virga, A., Scarpi, E., Fonzi, E., Musolino, A., Merloni, F., Sarti, S., Danesi, R., Ravegnani, M., Casadei, C., Sirico, M., Gianni, C., Maltoni, R., Bravaccini, S., Calistri, D., Arcangeli, V., Zampiga, V., Cangini, I., Bandini, E., …, & Tedaldi, G. (2025). Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants. The Oncologist. https://doi.org/10.1093/oncolo/oyaf052

Vancouver

Palleschi M, Virga A, Scarpi E, Fonzi E, Musolino A, Merloni F, et al. Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants. The Oncologist. 2025. doi:10.1093/oncolo/oyaf052

BibTeX
@article{Palleschi2025,
  author = {Palleschi, Michela and Virga, Alessandra and Scarpi, Emanuela and Fonzi, Eugenio and Musolino, Antonino and Merloni, Filippo and Sarti, Samanta and Danesi, Rita and Ravegnani, Mila and Casadei, Chiara and Sirico, Marianna and Gianni, Caterina and Maltoni, Roberta and Bravaccini, Sara and Calistri, Daniele and Arcangeli, Valentina and Zampiga, Valentina and Cangini, Ilaria and Bandini, Erika and Mannozzi, Francesca and Falcini, Fabio and Martinelli, Giovanni and De Giorgi, Ugo and Ulivi, Paola and Tedaldi, Gianluca},
  title = {Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyaf052}
}
Kostenlos starten →